<DOC>
	<DOC>NCT00281476</DOC>
	<brief_summary>The purpose of the study is to evaluate the effect of high doses of Simvastatine on bone metabolisme and biochemical markers of disease in Multiple Myeloma</brief_summary>
	<brief_title>The Effect of High Dose Simvastatine on Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms, Plasma Cell</mesh_term>
	<criteria>multiple myelomapatients in need of treatment stable og progressive disease age = or &gt; 18 years performance status &lt; 3 life expectancy &gt; 3 months pregnancy patients incapable of giving personally concent renal insufficiens with creatinine clearance below 25 ml/min alanin aminotransferasis &gt; 2,5 x upper reference limit thyroxine below lower reference limit known familiar muscledisease ar previous myopati creatinine kinase &gt; 10 x upper reference limit medication with drugs with known interactions wiht simvastatine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>multiple myeloma</keyword>
	<keyword>statins</keyword>
	<keyword>bone</keyword>
</DOC>